1. Immune-related adverse events are associated with a longer recurrence-free survival in patients with stage III melanoma treated with pembrolizumab....

1. There is no significant difference in 30-day all-cause mortality between radial and femoral access for percutaneous coronary intervention (PCI)...

1. Exposure to high levels of ambient fine particulate matter over time is significantly associated with incidence of stroke.fine p...

1. Antiepileptic drug exposure in infants of breastfeeding mothers being treated for epilepsy is low. Evidence Rating Level: 2 (Good) While...

1. In men with prostate cancer, functional outcomes following moderately hypofractionated radiation therapy are clinically equivalent to those following conventionally...

Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo:...

1. Obeticholic acid, a farnesoid X receptor agonist, prompts fibrosis improvement in patients with non-alcoholic steatohepatitis (NASH) Evidence Rating Level: 1...

1. Ixekizumab, an IL-17 inhibitor, elicits disease response in patients with non-radiographic active axial spondyloarthritis who have failed treatment with...

1. Children of mothers with diabetes are more likely to develop cardiovascular disease. Evidence Rating Level: 2 (Good) The prevalence of...

1.  A decrease in circulating progenitor cells during exercise stress-testing in patients with stable coronary artery disease is associated with...